Friday, 27 February 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 27 February 2026
News

Call for action on rare disease

Posted 27 February 2026 AM

MSD has led a call for action to improve diagnosis and treatment of Pulmonary Arterial Hypertension across the Asia Pacific.

The Declaration for Action on Pulmonary Arterial Hypertension (PAH): Advancing Early Diagnosis, Equitable Access, and Societal Momentum was written with patient groups, healthcare providers, and non-government organisations across the region to pledge a shared commitment to strengthen PAH awareness, speed diagnosis, and improve care in the Asia Pacific, which accounts for around 60 per cent of all PAH deaths worldwide.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (11)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (5)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.